Westhampton Capital’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $978K | Buy |
2,413
+168
| +7% | +$68.1K | 0.51% | 62 |
|
|
2025
Q1 | $1.12M | Sell |
2,245
-47
| -2% | -$23.4K | 0.61% | 56 |
|
|
2024
Q4 | $1.19M | Buy |
2,292
+75
| +3% | +$39K | 0.61% | 55 |
|
|
2024
Q3 | $1.37M | Buy |
2,217
+30
| +1% | +$18.6K | 0.7% | 51 |
|
|
2024
Q2 | $1.21M | Hold |
2,187
| – | – | 0.66% | 49 |
|
|
2024
Q1 | $1.27M | Sell |
2,187
-30
| -1% | -$17.4K | 0.69% | 50 |
|
|
2023
Q4 | $1.18M | Buy |
2,217
+60
| +3% | +$31.8K | 0.7% | 50 |
|
|
2023
Q3 | $1.09M | Buy |
2,157
+170
| +9% | +$86K | 0.7% | 50 |
|
|
2023
Q2 | $1.04M | Hold |
1,987
| – | – | 0.67% | 51 |
|
|
2023
Q1 | $1.15M | Hold |
1,987
| – | – | 0.74% | 48 |
|
|
2022
Q4 | $1.09M | Hold |
1,987
| – | – | 0.74% | 51 |
|
|
2022
Q3 | $1.01M | Hold |
1,987
| – | – | 0.76% | 49 |
|
|
2022
Q2 | $1.08M | Buy |
1,987
+62
| +3% | +$33.7K | 0.76% | 47 |
|
|
2022
Q1 | $1.14M | Hold |
1,925
| – | – | 0.73% | 46 |
|
|
2021
Q4 | $1.28M | Hold |
1,925
| – | – | 0.79% | 44 |
|
|
2021
Q3 | $1.1M | Hold |
1,925
| – | – | 0.75% | 46 |
|
|
2021
Q2 | $971K | Buy |
1,925
+200
| +12% | +$101K | 0.63% | 52 |
|
|
2021
Q1 | $787K | Sell |
1,725
-25
| -1% | -$11.4K | 0.54% | 59 |
|
|
2020
Q4 | $815K | Hold |
1,750
| – | – | 0.61% | 52 |
|
|
2020
Q3 | $773K | Hold |
1,750
| – | – | 0.63% | 49 |
|
|
2020
Q2 | $634K | Sell |
1,750
-100
| -5% | -$36.2K | 0.55% | 53 |
|
|
2020
Q1 | $525K | Buy |
1,850
+100
| +6% | +$28.4K | 0.55% | 55 |
|
|
2019
Q4 | $569K | Hold |
1,750
| – | – | 0.46% | 63 |
|
|
2019
Q3 | $510K | Hold |
1,750
| – | – | 0.43% | 64 |
|
|
2019
Q2 | $514K | Buy |
+1,750
| New | +$514K | 0.43% | 65 |
|